Literature DB >> 2668703

Skeletal muscle glutamine transport, intramuscular glutamine concentration, and muscle-protein turnover.

M J Rennie1, P A MacLennan, H S Hundal, B Weryk, K Smith, P M Taylor, C Egan, P W Watt.   

Abstract

This article reviews work we have carried out to investigate (1) the transport mechanisms responsible for the high distribution ratio of free glutamine commonly observed in skeletal muscle; (2) the fall in the distribution ratio that accompanies starvation, injury and chronic disease, whether directly involving muscle or not; and (3) the effect of modulation of intracellular free-glutamine concentration on protein synthesis and breakdown in skeletal muscle. We suggest that the results are consistent with the controlling role of the muscle membrane glutamine-sodium cotransporter in the regulation of the intracellular glutamine pool, the existence of pathophysiological mechanisms for the modulation of intramuscular glutamine and anabolic effects of glutamine in promoting protein synthesis, with a smaller effect in reducing protein breakdown. The mechanisms by which glutamine affects skeletal muscle protein turnover, and thus muscle protein balance, and the extent of the net flow of amino acids between the periphery and the viscera are unknown as yet, but the results suggest that modulation of transporter activity may offer the possibility of therapeutic intervention to reduce muscle wasting associated with injury and disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668703     DOI: 10.1016/0026-0495(89)90140-6

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  17 in total

1.  Responses of glutamine transport in cultured rat skeletal muscle to osmotically induced changes in cell volume.

Authors:  S Y Low; P M Taylor; M J Rennie
Journal:  J Physiol       Date:  1996-05-01       Impact factor: 5.182

2.  Whole body and skeletal muscle glutamine metabolism in healthy subjects.

Authors:  B Mittendorfer; E Volpi; R R Wolfe
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-02       Impact factor: 4.310

Review 3.  The emerging role of glutamine as an indicator of exercise stress and overtraining.

Authors:  D G Rowbottom; D Keast; A R Morton
Journal:  Sports Med       Date:  1996-02       Impact factor: 11.136

4.  Modulation of glycogen synthesis in rat skeletal muscle by changes in cell volume.

Authors:  S Y Low; M J Rennie; P M Taylor
Journal:  J Physiol       Date:  1996-09-01       Impact factor: 5.182

5.  The effects of glutamine-enriched total parenteral nutrition on tumor growth and host tissues.

Authors:  T R Austgen; P S Dudrick; H Sitren; K I Bland; E Copeland; W W Souba
Journal:  Ann Surg       Date:  1992-02       Impact factor: 12.969

6.  What's new in Emergencies, Trauma, and Shock? Nitrogen balance in critical patients on enteral nutrition.

Authors:  Luigi Beretta; Simona Rocchetti; Marco Braga
Journal:  J Emerg Trauma Shock       Date:  2010-04

7.  Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial.

Authors:  Elise Mok; Guy Letellier; Jean-Marie Cuisset; André Denjean; Frédéric Gottrand; Corinne Alberti; Régis Hankard
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240

8.  Substrate-specificity of glutamine transporters in membrane vesicles from rat liver and skeletal muscle investigated using amino acid analogues.

Authors:  S Y Low; P M Taylor; A Ahmed; C I Pogson; M J Rennie
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

9.  Influence of progressive tumor growth on glutamine metabolism in skeletal muscle and kidney.

Authors:  M K Chen; N J Espat; K I Bland; E M Copeland; W W Souba
Journal:  Ann Surg       Date:  1993-06       Impact factor: 12.969

10.  Efficiency of a cysteine-taurine-threonine-serine supplemented parenteral nutrition in an experimental model of acute inflammation.

Authors:  Sylwia Osowska; Jean-Pascal De Bandt; Samira Chaïb; Nathalie Neveux; Marie-Pierre Bérard; Luc Cynober
Journal:  Intensive Care Med       Date:  2003-07-17       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.